|
|
JDF Legislative Alert: Status of NIH Funding
June 24, 1996Call or Write Your Representative Regarding NIH Funding
The House Appropriations Subcommittee on Labor, HHS, and Education completed its mark-up of the FY 97 Appropriations bill for the National Institutes of Health on June 14th. We are delighted to report that the Subcommittee approved an increase of $820 million, or 6.9 percent, for NIH and an increase of $49 million for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). After adjusting for funding for the new NIH clinical center, the final increase for NIH's core research programs is 6.5 percent.The bill is expected to pass out of the House Appropriations Full Committee the week of June 24th, with passage on the House Floor expected the week of July 8th. The bill will then be considered by the Senate Appropriations Subcommittee on Labor, HHS, and Education, which expects to mark-up their version of the bill around July 18th.
Accordingly, we must now focus our attention on this Senate Subcommittee, the Senate Appropriations Full Committee, and the entire Senate.
This means it is crucial to generate as many letters, calls and/or faxes as possible to Senators from your state urging them to support an increase equal to that of the House, or more, for NIH funding, and an equal increase for NIDDK. Remember, JDF's recommended funding levels for FY 97 were an:
- 8 percent increase for the NIH or $12.9 billion in total funding.
- 8 percent increase for the NIDDK or $830.7 million in total funding.
- 8 percent increase for diabetes and diabetes related research throughout the NIH.
Senators on the Senate Appropriations Subcommittee on Labor, HHS, and Education must be contacted by July 16th. All other Senators should be contacted by July 22nd.
Some points to include in your letter:
- Your personal story.
- To seriously contain federal spending on health care, including Medicare and Medicaid, the federal investment in medical research must be maintained. There is ample evidence that an investment in medical research yields substantial savings in treatment costs. Research which leads to a cure for and prevention of diseases such as diabetes can potentially save the federal government and society billions in health care costs US$138 billion per year for diabetes alone.
- Cuts to the NIH would mean that the research engine that drives the biotechnology, pharmaceutical, and many other high-tech industries will be dramatically downsized, threatening America's world leadership in these important areas which account for hundreds of thousands of jobs.
- Much of the medical research currently funded through the NIH would not be conducted if federal funding is reduced. Private industry would find this research too risky an enterprise since there are no assurances that it will produce a marketable product or procedure.
Addresses:
The Honorable Name
U.S. Senate
Washington, D.C. 20510Dear Senator Last Name, or if writing Senator Specter it should be Dear Chairman Specter,
List of Senate Appropriations Labor, HHS, and Education Subcommittee Members who must be contacted by July 16th!
All other Senators must be contacted by Monday, July 22nd. Please send a copy of all correspondence to:
Majority Arlen Specter (R-PA) Chairman
Mark Hatfield (R-OR)
Thad Cochran (R-MS)
Slade Gorton (R-WA)
Connie Mack (R-FL)
Christoper S. Bond (R-MO)
James Jeffords (R-VT)
Judd Gregg (R-NH)
Minority Tom Harkin (D-IA) Ranking Member
Robert C. Byrd (D-WV)
Ernest F. Hollings (D-SC)
Daniel K. Inouye (D-HI)
Dale Bumpers (D-AR)
Harry Reid (D-LV)
Herbert Kohl (D-WI)
JDF Government Relations
1400 I Street, N.W., Suite 500
Washington, D.C. 20005If you have any questions or concerns contact Bill Schmidt or Eric Schutt at 1-800-JDF-1VOTE.
|
|
|||
Last Updated: Thu Aug 29 19:59:48 2002
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.
© Children with Diabetes, Inc. 1995-2009. Comments and Feedback.